Asia Cup final: India beat Malaysia 2-1 to win third Asia Cup title

Mumbai, May 21: Former India opener Gautam Gambhir has chosen legendary Sachin Tendulkar over current skipper Virat Kohli as a better batsman in the ODI format, considering the changed rules of the game and the Mumbaikar's longevity of career.

Tendulkar, who retired in 2013, played 463 ODIs and amassed 18, 426 runs with 49 hundreds at an average of 44.83.

Kohli, on the other hand, has played 248 ODIs and scored 11, 867 runs with 43 tons at an average of 59.33.

"Sachin Tendulkar, because probably with one white ball and four fielders inside the circle, not five fielders outside, it will be Sachin Tendulkar for me," Gambhir said on Star Sports show 'Cricket Connected'.

Nowadays, a one-day innings is played with two white balls and with three powerplays.

In the first power play (overs 1-10), two fielders are allowed beyond the 30-yard circle, while in the second powerplay (overs 10-40) four fielders are allowed. In the last powerplay (overs 40-50), five fielders are allowed outside the 30-yard circle.

Gambhir, who was the star performer in 2011 ODI World Cup final which India won, feels that the change in rules has helped batsmen.

"It's difficult because Virat Kohli has done phenomenally well but I think the rules have changed as well, which has helped a lot of new batters," elaborated Gambhir, who played 58 Tests and 147 ODIs.

"The new generation, with 2 new balls, no reverse swing, nothing for the finger spin, five fielders inside for the 50 overs, probably that makes batting much easier.

He said he would also go with Tendulkar, considering his longevity and flow of the ODI cricket format at that time.

"Probably I’ll go with Sachin Tendulkar if we see the longevity and flow of the one-day cricket format.

"Look at how Sachin Tendulkar has played, different rules, that time 230 to 240, was a winning total," Gambhir signed off. 

Jan 17: Indian tennis ace Sania Mirza cruised into the women's doubles final of the Hobart International with her Ukrainian partner Nadiia Kichenok here on Friday.

Sania and Kichenok sailed past the Slovenian-Czech pair of Tamara Zidansek and Marie Bouzkova 7-6 (3) 6-2 in the semifinal contest that lasted one hour and 24 minutes.

The fifth-seeded Indo-Ukrainian combination will lock horns with second seeds Shuai Peng and Shuai Zhang of China. The Chinese pair got a walkover after Belgium's Kirsten Flipkens and Alison Van Uytvanck conceded the other semifinal match because of injury.

While Sania and Kichenok had to fight hard in the opening set, the second set was a cakewalk for the combination.

The first set was a tough contest between the two pairs, bringing the tie-breaker into the equation after it was level at 6-6.

In the tie-breaker, Sania and Kichenok upped their game by a few notches to outsmart their opponents and take the lead.

The second set was a no-contest as Saina and Kichenok broke their opponents thrice -- in the second, sixth and eighth game -- to easily pocket the set and a place in the summit clash.

Saina and Kichenok got 11 break chances out of which they converted four, while their opponents utilised two out of the five break chances that came their way.

The 33-year-old Sania is returning to the WTA circuit after two years. During her time away from the game, she battled injury breakdowns before taking a formal break in April 2018 to give birth to her son Izhaan. She is married to Pakistani cricketer Shoaib Malik.

Before the ongoing event, Sania last played at China Open in October 2017.

A trailblazer in Indian tennis, Sania is a former world No.1 in doubles and has six Grand Slam titles to her credit.

She retired from the singles competition in 2013 after becoming the most successful Indian woman tennis player.

London/Milan, Jun 2: World Health Organization experts and a range of other scientists said on Monday there was no evidence to support an assertion by a high profile Italian doctor that the coronavirus causing the COVID-19 pandemic has been losing potency.

Professor Alberto Zangrillo, head of intensive care at Italy's San Raffaele Hospital in Lombardy, which bore the brunt of Italy's COVID-19 epidemic, on Sunday told state television that the new coronavirus "clinically no longer exists".

But WHO epidemiologist Maria Van Kerkhove, as well as several other experts on viruses and infectious diseases, said Zangrillo's comments were not supported by scientific evidence.

There is no data to show the new coronavirus is changing significantly, either in its form of transmission or in the severity of the disease it causes, they said.

"In terms of transmissibility, that has not changed, in terms of severity, that has not changed," Van Kerkhove told reporters.

It is not unusual for viruses to mutate and adapt as they spread, and the debate on Monday highlights how scientists are monitoring and tracking the new virus. The COVID-19 pandemic has so far killed more than 370,000 people and infected more than 6 million.

Martin Hibberd, a professor of emerging infectious disease at the London School of Hygiene & Tropical Medicine, said major studies looking at genetic changes in the SARS-CoV-2 virus that causes COVID-19 did not support the idea that it was becoming less potent, or weakening in any way.

"With data from more than 35,000 whole virus genomes, there is currently no evidence that there is any significant difference relating to severity," he said in an emailed comment.

Zangrillo, well known in Italy as the personal doctor of former Prime Minister Silvio Berlusconi, said his comments were backed up by a study conducted by a fellow scientist, Massimo Clementi, which Zangrillo said would be published next week.

Zangrillo told Reuters: "We have never said that the virus has changed, we said that the interaction between the virus and the host has definitely changed."

He said this could be due either to different characteristics of the virus, which he said they had not yet identified, or different characteristics in those infected.

The study by Clementi, who is director of the microbiology and virology laboratory of San Raffaele, compared virus samples from COVID-19 patients at the Milan-based hospital in March with samples from patients with the disease in May.

"The result was unambiguous: an extremely significant difference between the viral load of patients admitted in March compared to" those admitted last month, Zangrillo said.

Oscar MacLean, an expert at the University of Glasgow's Centre for Virus Research, said suggestions that the virus was weakening were "not supported by anything in the scientific literature and also seem fairly implausible on genetic grounds."